In another inflection point for the psychedelic medicines category, Mind Medicine (MindMed) has claimed breakthrough status from the FDA for its LSD-based candidate MM120 as a treatment for anxiety.

In 1943, biochemist Albert Hoffman accidentally ingested a chemical that he had synthesized from a fungus and discovered that it created hallucinations. The mind-bending chemical was lysergic acid ...

Check out Random Hacks V8 for the freshest and smartest life hacks! This video features creative solutions to common problems, clever DIY ideas, and handy tips that make daily tasks easier and more ...

A new study suggests that lysergic acid diethylamide (LSD), also known as acid, could reduce anxiety. This marks the first-ever trial to evaluate the safety and efficacy of MM120 (a pharmaceutical ...

A recent study by MindMed reveals that LSD could be a potential treatment for anxiety. A single dose significantly reduced anxiety symptoms in individuals with generalized anxiety disorder, with ...

The study enrolled 198 adults with anxiety at 22 sites across the U.S. Once a symbol of 1960s counterculture, the drug lysergic acid diethylamide, commonly known as LSD, is emerging from research labs ...

LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for ...

A mid-stage study of a pharmaceutical version of the psychedelic LSD reported the drug might help alleviate anxiety symptoms for up to three months, advancing a potential treatment for the most common ...

Studio LSD IPO opened on August 18 and will close on August 20, with a price band of ₹51-54.(Company website) Studio LSD Limited is a multimedia production company that focuses on creating original ...

MAKING AMERICA THE LEADER IN DIGITAL ASSETS: Today, President Donald J. Trump signed the GENIUS Act into law, a historic piece of legislation that will pave the way for the United States to lead the ...

A team of researchers at the University of California, Davis, made small tweaks to the molecular structure of lysergic acid diethylamide (LSD) to see if it could be turned into an effective ...